X7 Research Company participates in the three-days DIA conference. The topic of the conference is “Pharmacovigilance and Risk Management Strategies”.
The content of this event was developed by top experts from the biopharmaceutical industry and global regulatory agencies, and DIA will convene the best speakers from around the world to discuss the current challenges and issues that matter most to professionals working in the field.
This year, regulators and industry experts will take an in-depth look at global harmonization of ICH E19, addressing optimization of safety data collection. Insights and forward-thinking approaches to pharmacovigilance and risk management to ensure the safety of existing as well as advanced new therapies as these enter development and the postmarket setting will be discussed. Projects applying cutting edge technologies like machine learning/artificial intelligence to manage large volumes of potential safety data will be examined.
The conference was launched on January 22 and will last until January 24. The capital of the USA – Washington DC was chosen as the city for this event.
More details on the materials and subtopics of the conference you can find on our website. And also see other events that our company plans to visit in 2018. You can find an event that you are interested in and contact us by email email@example.com. We will be glad to meet you at this and the following events!